Grants and Contributions:

Title:
Canadian Immunization Research Network: COVID-19 Vaccine Readiness Funding Opp
Agreement Number:
157916
Agreement Value:
$3,516,000.00
Agreement Date:
Sep 1, 2020 - Mar 31, 2022
Description:
The purpose of this funding opportunity is to support readiness preparations for CIRN to undertake urgent activities related to COVID-19 vaccine clinical trials and to provide vaccine-related research outcomes that will inform effective, equitable and timely COVID-19 public health decision-making. The proposal will address ALL of the following objectives: • Act with a sense of urgency and coordinate with all relevant stakeholders, including federal, provincial and territorial partners, to ensure Canadian readiness for COVID-19 vaccine clinical trials. Meeting this objective will help to ensure sufficient COVID-19 vaccine clinical trial capacity and infrastructure are in place when needed and will support the accelerated evaluation of COVID-19 vaccine(s) in Canada. • Proactively communicate with all relevant national and international stakeholders to ensure CIRN is aware of, and aligned with (wherever possible), global COVID-19 vaccine clinical trial strategies to provide the highest possible level of evidence on the safety and efficacy of COVID-19 vaccine(s). • Assess various models of population prioritization and perform modelling to support the development of evidence-based recommendations for effective and equitable program design and implementation, and knowledge mobilization to mitigate the COVID-19 pandemic. • Prepare the general public, high-risk populations and the public health community for deployment of COVID-19 vaccine(s), which includes coordinating and/or conducting research related to vaccine hesitancy, acceptance and uptake, and the identification of targeted and culturally appropriate communication and roll-out strategies to optimize uptake. • Seek opportunities for harmonized data collection, open data sharing, and real-world data sharing with relevant knowledge-users to support a timely and effective COVID-19 public health response within and across all jurisdictions in Canada.
Organization:
Canadian Institutes of Health Research
Expected Results:

This program provides funding for targeted grants and awards aimed at addressing priority areas. Priorities are identified by CIHR in consultation with other government departments and agencies, partners and stakeholders. The program mobilizes researchers, patients, health providers, and decision makers to conduct research, enable knowledge translation and build capacity in the priority areas. It often requires collaboration within and across sectors.

Location:
Halifax, Nova Scotia, CA B3H 3J5
Reference Number:
236-2020-2021-Q2-00230
Agreement Type:
Grant
Report Type:
Grants and Contributions
Recipient Type:
Individual or sole proprietorship
Additional Information:

Amendment 1: Projected Agreement End Date.

Amendment Date
Jun 30, 2021
Recipient's Legal Name:
Halperin, Scott A
Research Organization:
Dalhousie University (Nova Scotia)
Program:
Research in Priority Areas
Program Purpose:

This program provides funding for targeted grants and awards aimed at addressing priority areas. Priorities are identified by CIHR in consultation with other government departments and agencies, partners and stakeholders. The program mobilizes researchers, patients, health providers, and decision makers to conduct research, enable knowledge translation and build capacity in the priority areas. It often requires collaboration within and across sectors.

Amendments: